Litaba
Liphello tse Tšepisang tsa CD7 CAR-T Therapy e Kopantsoeng le Phetolelo ea Bobeli ho Bakuli ba Khutlileng ba T-ALL/LBL
Phuputso ea morao tjena e totobatsa katleho ea phekolo ea CD7 CAR-T e lateloang ke allogeneic hematopoietic stem cell transplantation (HSCT) ho bakuli ba khutletseng hape T-cell acute lymphoblastic leukemia (T-ALL) le lymphoblastic lymphoma (LBL), e bontšang bokhoni ba bohlokoa ho ho finyella lefu le fokolang la ho salla (MRD) -negative e feletseng ea tšoarelo.
Tšebeliso ea nako e telele ea CD19 CAR T-Cell Therapy ho Phekolo ea Relapsed/Refractory Acute Lymphoblastic Leukemia.
Boithuto bo matla bo bonts'a katleho ea nako e telele ea CD19 CAR T-cell therapy ho alafa bakuli ba nang le lefu la ho khutla hape / refractory acute lymphoblastic leukemia (ALL) ka mor'a phetisetso ea li-allogeneic hematopoietic stem cell transplantation, e fanang ka tšepo e ncha ho hematology.
Bioocus e Tsoela Pele ho Phekolo ea Acute Lymphoblastic Leukemia
Bioocus e ka pele ho nts'etsopele ea liphekolo tsa CAR-T tsa moloko o latelang. Sengoliloeng sa morao-rao sa Dr. Chunrong Tong le sehlopha sa hae Sepetlele sa Lu Daopei se totobatsa tsoelo-pele e matla le liphephetso ts'ebelisong ea liphekolo tsa CD19 CAR-T tsa moloko oa bobeli ho bakuli ba bana, ho bonts'a boitlamo ba Bioocus ho kalafo e ncha ea mofets'e.
Phekolo ea Bopula-maliboho ea CAR-T ho B-cell Acute Lymphoblastic Leukemia e bonts'a katleho e sa lebelloang
Boithuto bo matla bo totobatsa katleho e makatsang ea CAR-T cell therapy ho alafa B-cell Acute Lymphoblastic Leukemia (B-ALL). Patlisiso, e kenyelletsang tšebelisano 'moho le BIOOCUS le Sepetlele sa Lu Daopei, e bonts'a tsoelo-pele e kholo, ho theha kalafo e le khetho ea bohlokoa ea kalafo.
Mekhoa e Mecha ea Phekolo ea Lisele ea CAR-T e Fetola Phekolo ea Mafu a B Cell
Bafuputsi ba Sepetlele sa Lu Daopei le basebetsi-'moho le bona ba machaba ba hlahloba mekhoa ea phekolo ea lisele tsa CAR-T, e fanang ka tšepo bakeng sa bakuli ba nang le bokooa ba B cell. Phuputso ena e totobatsa tsoelo-pele ea moralo le ts'ebeliso, e bonts'a liphetho tse ts'episang le monyetla oa lintlafatso tsa nako e tlang.
Matla a Ntlafetseng a Antitumor a 4-1BB-Based CD19 CAR-T Cells ho Phekolo B-ALL
Liphuputso tsa morao-rao tsa kliniki li senola hore lisele tsa CD19 CAR-T tsa 4-1BB li bontša katleho e phahameng ea antitumor ha e bapisoa le lisele tsa CAR-T tse thehiloeng ho CD28 ho phekola B cell acute lymphoblastic leukemia (r/r B-ALL).
Therapy ea CD19 CAR-T ea Sepetlele sa Lu Daopei e bonts'a Liphetho tse Tšepisang ho Bakuli ba B-ALL
Phuputso ea morao-rao Sepetleleng sa Lu Daopei e bonts'itse katleho e phahameng le polokeho ea kalafo ea lisele tsa CD19 CAR-T tsa tekanyetso e tlase ho alafa bakuli ba B acute lymphoblastic leukemia (B-ALL) ba refractory kapa ba khutletseng hape. Patlisiso, e neng e kenyelletsa bakuli ba 51, e bonts'itse sekhahla se makatsang sa phokolo e nang le litlamorao tse fokolang.
Leano la Novel Promoter le Ntlafatsa Polokeho le Matla a Phekolo ea CAR-T ho Acute B Cell Leukemia.
Sepetlele sa Lu Daopei le Hebei Senlang Biotechnology li phatlalalitse liphetho tse ts'episang ho tsoa liphuputsong tsa bona tsa morao-rao mabapi le polokeho le katleho ea kalafo ea CAR-T bakeng sa acute B cell leukemia. Tšebelisano ena e totobatsa bokhoni ba meralo ea lisele tsa CAR-T ho ntlafatsa sephetho sa bakuli.
Thuto e Fetileng e Bontša Tšireletseho le Matla a Phekolo ea CAR-T ho Phekoleng Mafu a B-Cell
Phuputso e ncha e etelletsoeng pele ke Dr. Zhi-tao Ying oa Sepetlele sa Kankere ea Univesithi ea Peking e bontšitse tšireletseho le katleho ea IM19 CAR-T cell therapy ho phekola li-B-cell hematologic malignancies tse khutlelang morao le tse hanyetsang. E hatisitsoe hoChinese Journal of New Lithethefatsi, phuputso e tlaleha hore bakuli ba 11 ho ba 12 ba finyelletse tšoarelo e feletseng ntle le liphello tse mpe tse matla, ho bontša bokhoni ba IM19 e le khetho e tšepisang ea phekolo bakeng sa bakuli ba nang le mekhoa e meng e fokolang.
Tsoelo-pele e Tsoelang Pele Liseleng tsa 'Molai oa Tlhaho (NK) Ho feta Lilemo tse 50
Lilemong tse mashome a mahlano tse fetileng, lipatlisiso ka lisele tsa Natural Killer (NK) li fetotse kutloisiso ea rona ea ts'ireletso ea tlhaho ea 'mele, e fana ka mekhoa e mecha e tšepisang bakeng sa mofetše le kalafo ea vaerase.
Koetliso ea Selemo le Selemo ea Tsamaiso ea Mali ea Tleliniki le Ts'ebetso ea Ts'ebetso e Ts'oaretsoeng Sepetleleng sa Yanda Ludaopei
Koetliso ea Selemo le Selemo ea 2024 ea Clinical Blood Management and Transfusion Technology e Sanhe City e ile ea tšoaroa ka katleho Sepetlele sa Yanda Ludaopei. Ketsahalo ena e ikemiselitse ho ntlafatsa taolo ea mali ea bongaka le polokeho ea tšelo ea mali ka lithupelo tse felletseng tse nang le litsebi tse fetang 100 tsa tlhokomelo ea bophelo tse tsoang litsing tse fapaneng tsa bongaka.
Katleho ho Mafu a Ikemetseng a Bana: Phekolo ea Lisele ea CAR-T e Phekola Mokuli oa Lupus
Thuto ea bopula-maliboho Sepetleleng sa Univesithi ea Erlangen e atlehile ho phekola ngoanana ea lilemo li 16 ea nang le lefu le matla la systemic lupus erythematosus (SLE) a sebelisa CAR-T cell therapy. Sena se tšoaea tšebeliso ea pele ea kalafo ena bakeng sa lupus ea bana, e fanang ka tšepo e ncha bakeng sa bana ba nang le mafu a autoimmune.